AstraZeneca Proprietary Ltd.

International subsidiary
5 Alma Rd., North Ryde,  NSW 2113, Australia
()61 02 9978 3500, 61 02 9978 3700 fax, http://www.astrazeneca.com.au

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture and distribution of ethical pharmaceuticals; research and development

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

AstraZeneca Proprietary Ltd., News and Information

Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin.
PR Newswire; 11/9/2009; 885 words; ...marketing of branded generic and proprietary pharmaceuticals in China...Tianda Pharmaceutical Co., Ltd. ("Tianda"). The acquisition...Rosuvastatin was first marketed by Astrazeneca as Crestor in 2003 and is...marketing of branded generic and proprietary pharmaceuticals in China...

XOMA Gets $30 Million Upfront In Pfizer Technology Deal.
BIOWORLD Today; 11/3/2009; 1069 words; ...Writer Shares of XOMA Ltd. rose 18 percent on...Takeda Pharmaceutical Co. Ltd., among others. This...working hard to move the proprietary pipeline forward...for $2.2 billion, AstraZeneca plc took over Cambridge...billion, Eisai Co. Ltd bought Morphotek Inc...

Other News To Note.
BIOWORLD Today; 11/3/2009; 1416 words; ...Boulder, Colo., and AstraZeneca AB, of London, selected...milestone payment from AstraZeneca to Array. The second...commercialization with AstraZeneca. MEK is a critical...rules. o EvoGenix Ltd., of Sydney, Australia...EvoGenix will apply its proprietary technologies to advance...

Biocompatibles International plc - Statement re Positive Data in Combination Therapy Trial.
PR Newswire UK Disclose; 11/3/2009; 1933 words; ...Terumo Corporation and Eisai Co. Ltd. We have a clinical collaboration agreement...for the treatment of stroke, based on proprietary stem cell technology; a GLP-1 analogue...of diabetes and obesity partnered with AstraZeneca; and a cosmetic Dermatology Bead partnered...

Zacks Analyst Blog Highlights: Lennar Corp., VeriChip, Sanofi-Aventis, AstraZeneca and Novartis.
Business Wire; 9/22/2009; 1813 words; ...Sanofi-Aventis SA (SFY), AstraZeneca (AZN) and Novartis AG...Aventis SA (SFY), CSL Ltd, MedImmune (now a subsidiary of AstraZeneca [AZN]) and Novartis AG...was the formation of his proprietary stock picking system; the...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.